Combining expert medical imaging services of VirtualScopics and the cardiac core lab leadership of Cardiocore — for the advancement of biopharmaceutical development worldwide
As experts in medical imaging and cardiac safety testing for clinical trials, the hard-working people at BioTel Research provide the ideal combination of personal service, global reach, scientific expertise, and on-time data delivery.
Now offering the expertise of VirtualScopics, BioTel Research provides comprehensive medical imaging services for clinical trials, including all major modalities for Oncology, Cardiovascular, Musculoskeletal, Neurologic, and imaging for Metabolic Diseases. MORE
BioTel Research, formerly Cardiocore, has been a leader in the cardiac core lab industry since the 1990s. Now, we continue to offer comprehensive, global services, including ECG, Event, Blood Pressure, and Holter monitoring, as well as ECHO and MUGA studies for clinical trials. MORE
Visit BioTelemetry, Inc. at booth #543 the HRS 39th Annual Scientific Sessions to learn more about the latest advancements in cardiac monitoring patch technology from BioTel Heart: MCOT Patch and ePatch.
May 9-12, 2018
Stop by booth #26 to meet with our VP of Oncology Imaging, Ed Ashton, PhD, to learn more about response assessment in Immune-Oncology.
April 24-25, 2018
Mar 26, 2018
In this free webinar, BioTel Research’s Vice President of Musculoskeletal and Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, present alternative, noninvasive imaging methods to determine body composition.
Feb 13, 2018 | 11:00 AM
Immunotherapy is an emerging class of cancer treatment, which stimulates the body’s immune system to fight cancer. With the approval of three checkpoint inhibitors (ipilimumab, pembrolizumab and nivolumab) by the FDA in the past five years, immunotherapies are seen as exciting treatments able to elicit durable cures. Download our white paper to discover: Emerging immunotherapeutic […]
Jun 1, 2016
As we know, more attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications, especially when these are not anticipated or thoroughly defined during drug development. Discovering negative results for BP elevation in early trials, would allow more informed planning for BP safety monitoring in later trials. Download […]
Nov 3, 2014
CLINICAL TRIALS SUPPORT:
Toll Free: 1.877.324.8326
One Preserve Parkway
Rockville, MD 20852
155 Corporate Woods
Rochester, NY 14623
400 Oyster Point Blvd
South San Francisco, CA 94080
Building 3 Chiswick Park
566 Chiswick High Road
London, W4 5YA
Kabutocho Daiichi Heiwa
Connect with Us for the latest on our clinical trials services, including medical imaging and cardiac safety testing